Letter: screening for infectious side effects in patients with IBD-the importance and potential of real-world remote monitoring

Aliment Pharmacol Ther. 2022 Jan;55(2):260-261. doi: 10.1111/apt.16707.

Authors

Ashkan Rezazadeh Ardabili^{1

2}, Zlatan Mujagic^{1

2}, Daisy M A E Jonkers^{1

2}, Marie J Pierik^{1

2}

Affiliations

¹ School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center+, Maastricht, The Netherlands.
² Department of Internal Medicine, Division of Gastroenterology and Hepatology, Maastricht University Medical Center+, Maastricht, The Netherlands.

PMID: 34970770
DOI: 10.1111/apt.16707

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Drug-Related Side Effects and Adverse Reactions*
Humans
Inflammatory Bowel Diseases* / diagnosis
Mass Screening
Telemedicine*